#NephMadness 2018: Patient-Centered Care Medicine – The Future
Fredric O. Finkelstein, MD Dr. Finkelstein is Clinical Professor of Medicine at Yale University. He is Chair of the CME Program of the ISN and Chair of the International [...]
NM18Trials
#NephMadness 2018: The True Titan of Trials – Patient-Reported Outcome Measures
Kerri Cavanaugh, MD Dr. Cavanaugh is an Associate Professor of Medicine at Vanderbilt University School of Medicine and Medical Director of the Vanderbilt Dialysis [...]
#NephMadness 2018: 40% Is Good Enough
Navdeep Tangri, MD Dr. Tangri is an Associate Professor in the Department of Medicine at the University of Manitoba. He is interested in the trajectory of patients with [...]
#NephMadness 2018: Covic’s Thoughts on the Proteinuria Team’s Chances
Adrian Covic, MD Prof. Covic is a Professor of Nephrology and Internal Medicine at the “Grigore T. Popa” University of Medicine and Pharmacy, the Director of the [...]
#NephMadness 2018: 40% eGFR Decrease and Other New Kids on the Block
Sunil Badve, MD Dr. Badve is at St George Hospital in Sydney, Australia and Conjoint Associate Professor of Medicine at the University of New South Wales. Follow [...]
#NephMadness 2018: Mark’s Bracketology for Trial Outcomes
Patrick Mark, MB, ChB, FRCP, PhD Dr. Mark is Reader in Nephrology at the University of Glasgow and an Honorary Consultant Nephrologist at the Queen Elizabeth University [...]
#NephMadness 2018: Bakris on Trial Outcomes
George L. Bakris, MD Dr. Bakris is a nephrologist/hypertension specialist who dedicates his time to the diagnosis and reduction of high blood pressure, particularly in [...]
#NephMadness 2018: Trial Outcomes Region
Submit your picks! | NephMadness 2018 | #NephMadness | #TrialsRegion Selection Committee Member for the Trial Outcomes Region: Jamie P. Dwyer, MD Dr. Dwyer is Professor [...]